Facet Life Sciences Recognized in Top 10 Regulatory Services Companies for 2023
Facet Life Sciences, a leading provider of regulatory strategy and [...]
Potential Errors and Corrections in Early Phase Drug Development
Expertise from our Partner Potential Errors and [...]
Theragnostics Announces US FDA Approval for its Radiodiagnostic Imaging Drug NephroScanTM
Theragnostics Announces US FDA Approval for its Radiodiagnostic Imaging [...]
Facet Life Sciences Announces Spinout of Software Division to a New Company: Kivo
Facet Life Sciences Announces Spinout of Software Division to a [...]
Are You a Drug or Device?
Are You a Drug or Device? Unseen Regulatory [...]
Facet Life Sciences Redefines NDA Timelines – Shattering Industry Standards
FDA files NDAs submitted less than six seeks after completion [...]
Facet Life Sciences Appoints New Chief Operating Officer
R&D Executive Promoted to Ensure Continued Services and Technology Growth [...]
FDA Meetings: When More Meetings are a Good Thing!
Most of us are trying to simplify our schedules and [...]
FDA and Intellectual Property Strategies for Medical Device Technologies
Book on Regulatory Practice and Intellectual Property Now Available Wayne, [...]
The Sky is Not Falling: Product Development Can and Should Progress During The Government Shut Down!
The effects of the U.S. government shut down and the [...]
gET sOCIAL